Salinomycin Derivatives Kill Breast Cancer Stem Cells via Lysosomal Iron Targeting.

This study provides highly selective molecules to target the CSC niche, a potential interesting advance for drug development to prevent cancer resistance.
PMID: 32083773 [PubMed - as supplied by publisher]

Source: Chemistry - February 20, 2020 Category: Chemistry Authors: Versini A, Colombeau L, Hienzsch A, Gaillet C, Retailleau P, Debieu S, Müller S, Cañeque T, Rodriguez R Tags: Chemistry Source Type: research